GlassScriptPhysician profile
Jenny Lam
NPI 1275915415
$4,615.63
in general payments reported to CMS, 2019-2025
16 companies · $674 in 2025
The $674 reported for 2025 was more than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,405 · 2024: $536 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,408 · Food and Beverage: $1,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,407.73 |
| Food and Beverage | $1,207.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $2,179.64 | 2023-2024 | Organ Care System |
| Merck Sharp & Dohme LLC | $1,798.42 | 2023-2025 | Prevymis, Zerbaxa, Dificid |
| Madrigal Pharmaceuticals | $147.66 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $86.55 | 2025 | Livtencity, Eohilia |
| Phathom Pharmaceuticals, INC. | $61.02 | 2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $53.01 | 2025 | |
| Lilly USA, LLC | $51.77 | 2025 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $51.20 | 2025 | Dupixent |
| Genzyme Corporation | $36.18 | 2025 | |
| Azurity Pharmaceuticals, INC. | $29.58 | 2025 | Triptodur |
| Daiichi Sankyo INC. | $26.98 | 2024 | Injectafer |
| Veloxis Pharmaceuticals, INC. | $23.74 | 2024 | Envarsus |
| Orphalan INC | $21.04 | 2025 | Cuvrior |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.69 | 2024 | Xifaxan |
| Exelixis INC. | $17.22 | 2025 | Cabometyx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eurofins Viracor, LLC | $13.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.